|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT00213720 |
|
Date of registration:
|
13/09/2005 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Treatment of Subclinical Hyperthyroidism
|
|
Scientific title:
|
Place de l'Iode RadioActif Dans l'HyperThyroïdiE Sub-clinique (PIRHATES)/ Evaluation of the Interest of Subclinical Hyperthyroidism Treatment |
|
Date of first enrolment:
|
August 2005 |
|
Target sample size:
|
145 |
|
Recruitment status: |
Terminated |
|
URL:
|
https://clinicaltrials.gov/show/NCT00213720 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Bernard Goichot, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hopitaux Universitaires de Strasbourg |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Men and women aged 50 and greater
- Isolated decreased thyroid-stimulating hormone (TSH) with normal FT4 and FT3 levels
Exclusion Criteria:
- Iodide overload
- Non sinusal heart rhythm
- Severe heart disease
Age minimum:
50 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Atrial Fibrillation
|
|
Subclinical Hyperthyroidism
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|